N.D. Sonawane

2.5k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

N.D. Sonawane is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, N.D. Sonawane has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in N.D. Sonawane's work include Cystic Fibrosis Research Advances (10 papers), Ion channel regulation and function (4 papers) and Neonatal Respiratory Health Research (3 papers). N.D. Sonawane is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Ion channel regulation and function (4 papers) and Neonatal Respiratory Health Research (3 papers). N.D. Sonawane collaborates with scholars based in United States, Italy and Japan. N.D. Sonawane's co-authors include A.S. Verkman, Francis C. Szoka, A. S. Verkman, Luis J. V. Galietta, Chatchai Muanprasat, Danieli B. Salinas, Jay R. Thiagarajah, Alessandro Taddei, Baoxue Yang and A. S. Verkman and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Gastroenterology.

In The Last Decade

N.D. Sonawane

17 papers receiving 2.0k citations

Hit Papers

Chloride Accumulation and Swelling in Endosomes Enhances ... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.D. Sonawane United States 15 1.4k 496 343 136 127 17 2.1k
Paul H. Johnson United States 23 1.1k 0.8× 118 0.2× 248 0.7× 139 1.0× 23 0.2× 43 2.1k
Wakana Ohashi Japan 21 2.2k 1.6× 75 0.2× 491 1.4× 103 0.8× 70 0.6× 36 3.1k
Jiyuan Ke United States 23 1.4k 1.0× 76 0.2× 135 0.4× 188 1.4× 28 0.2× 40 2.4k
Mitsuru Hashida Japan 23 1.1k 0.8× 66 0.1× 344 1.0× 180 1.3× 51 0.4× 40 1.9k
Pierre Lemieux Canada 18 1.1k 0.8× 60 0.1× 348 1.0× 157 1.2× 97 0.8× 38 1.8k
Connie Cheng United States 17 767 0.6× 70 0.1× 176 0.5× 266 2.0× 48 0.4× 25 1.5k
Kelly M. Stewart Canada 12 1.9k 1.4× 156 0.3× 168 0.5× 281 2.1× 29 0.2× 15 3.4k
Minh Lam United States 29 1.3k 1.0× 680 1.4× 162 0.5× 518 3.8× 14 0.1× 55 2.4k
Grazia Galleri Italy 26 502 0.4× 75 0.2× 235 0.7× 214 1.6× 45 0.4× 68 1.9k

Countries citing papers authored by N.D. Sonawane

Since Specialization
Citations

This map shows the geographic impact of N.D. Sonawane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.D. Sonawane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.D. Sonawane more than expected).

Fields of papers citing papers by N.D. Sonawane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.D. Sonawane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.D. Sonawane. The network helps show where N.D. Sonawane may publish in the future.

Co-authorship network of co-authors of N.D. Sonawane

This figure shows the co-authorship network connecting the top 25 collaborators of N.D. Sonawane. A scholar is included among the top collaborators of N.D. Sonawane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.D. Sonawane. N.D. Sonawane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tradtrantip, Lukmanee, N.D. Sonawane, W. Namkung, & A. S. Verkman. (2009). Nanomolar Potency Pyrimido-pyrrolo-quinoxalinedione CFTR Inhibitor Reduces Cyst Size in a Polycystic Kidney Disease Model. Journal of Medicinal Chemistry. 52(20). 6447–6455. 72 indexed citations
2.
Sonawane, N.D., Dan Zhao, Olga Zegarra‐Moran, Luis J. V. Galietta, & A. S. Verkman. (2008). Nanomolar CFTR Inhibition by Pore-Occluding Divalent Polyethylene Glycol-Malonic Acid Hydrazides. Chemistry & Biology. 15(7). 718–728. 27 indexed citations
3.
Sonawane, N.D., Olga Zegarra‐Moran, W. Namkung, Luis J. V. Galietta, & A. S. Verkman. (2008). α-Aminoazaheterocyclic-Methylglyoxal Adducts Do Not Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Activity. Journal of Pharmacology and Experimental Therapeutics. 325(2). 529–535. 2 indexed citations
4.
Sonawane, N.D. & A. S. Verkman. (2008). Thiazolidinone CFTR inhibitors with improved water solubility identified by structure–activity analysis. Bioorganic & Medicinal Chemistry. 16(17). 8187–8195. 48 indexed citations
5.
Yang, Baoxue, N.D. Sonawane, Dan Zhao, Stefan Somlo, & A. S. Verkman. (2008). Small‐Molecule CFTR Inhibitors Slow CYST Growth in Culture and Mouse Models of Polycystic Kidney Disease. The FASEB Journal. 22(S1). 2 indexed citations
6.
Sonawane, N.D., Dan Zhao, Olga Zegarra‐Moran, Luis J. V. Galietta, & A. S. Verkman. (2007). Lectin Conjugates as Potent, Nonabsorbable CFTR Inhibitors for Reducing Intestinal Fluid Secretion in Cholera. Gastroenterology. 132(4). 1234–1244. 44 indexed citations
7.
Zhao, Dan, N.D. Sonawane, Marc H. Levin, & Baoxue Yang. (2007). Comparative transport efficiencies of urea analogues through urea transporter UT-B. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(7). 1815–1821. 52 indexed citations
8.
Fuente, Ricardo de la, et al.. (2006). Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high‐throughput screening. British Journal of Pharmacology. 149(5). 551–559. 103 indexed citations
9.
Pedemonte, Nicoletta, N.D. Sonawane, Alessandro Taddei, et al.. (2005). Phenylglycine and Sulfonamide Correctors of Defective ΔF508 and G551D Cystic Fibrosis Transmembrane Conductance Regulator Chloride-Channel Gating. Molecular Pharmacology. 67(5). 1797–1807. 127 indexed citations
10.
Sonawane, N.D., Jie Hu, Chatchai Muanprasat, & A. S. Verkman. (2005). Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera. The FASEB Journal. 20(1). 130–132. 40 indexed citations
11.
Song, Yuanlin, N.D. Sonawane, Danieli B. Salinas, et al.. (2004). Evidence against the Rescue of Defective ΔF508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse Models. Journal of Biological Chemistry. 279(39). 40629–40633. 92 indexed citations
12.
Sonawane, N.D., et al.. (2004). In Vivo Pharmacology and Antidiarrheal Efficacy of a Thiazolidinone CFTR Inhibitor in Rodents. Journal of Pharmaceutical Sciences. 94(1). 134–143. 32 indexed citations
13.
Muanprasat, Chatchai, N.D. Sonawane, Danieli B. Salinas, et al.. (2004). Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors. The Journal of General Physiology. 124(2). 125–137. 221 indexed citations
14.
Hara‐Chikuma, Mariko, Baoxue Yang, N.D. Sonawane, et al.. (2004). ClC-3 Chloride Channels Facilitate Endosomal Acidification and Chloride Accumulation. Journal of Biological Chemistry. 280(2). 1241–1247. 151 indexed citations
15.
Sonawane, N.D., Francis C. Szoka, & A.S. Verkman. (2003). Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes. Journal of Biological Chemistry. 278(45). 44826–44831. 854 indexed citations breakdown →
16.
Sonawane, N.D. & A. S. Verkman. (2003). Determinants of [Cl−] in recycling and late endosomes and Golgi complex measured using fluorescent ligands. The Journal of Cell Biology. 160(7). 1129–1138. 61 indexed citations
17.
Sonawane, N.D., Jay R. Thiagarajah, & A.S. Verkman. (2002). Chloride Concentration in Endosomes Measured Using a Ratioable Fluorescent Cl− Indicator. Journal of Biological Chemistry. 277(7). 5506–5513. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026